SynthesisPloS one2024

The efficacy and safety of immune-checkpoint inhibitors plus chemotherapy versus chemotherapy for non-small cell lung cancer: An updated systematic review and meta-analysis.

Jing Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.